In conclusion, while there is a sound scientific basis for the potential benefits of GLP-1/GIP receptor agonists in T1D with overweight or obesity, the clinical evidence is still evolving, and larger, more rigorous clinical trials are necessary to establish their efficacy, optimal usage protocols, and safety in this specific patient population
With a combination of vitamins and an anti-nausea medication, our Morning Sickness Relief IV can alleviate your symptoms and leave you feeling energized and refreshed
Intraperitoneal glucose tolerance tests Mice were fasted overnight (HFHS mice) or the morning of the procedure (lean mice)

#CKMSyndrome #CardioRenalMetabolic #Diabetes #Endocrinology #Nephrology #Cardiology #ObesityMedicine #SGLT2 #GLP1 #PreventiveCardiology #MedicalEducation #CKD #Type2Diabetes #CardiometabolicHealth #AHA #ACC #ADA #ASN To view or add a comment, sign in Excellent summary and infographic of cardio-renal-metabolic syndrome by Ismail Abdelkhalek By treating Obesity we aim at much more than reducing body weight - we can prevent or attenuate cardio-renal-metabolic complications * Internal Medicine Specialist & Medical Director Candidate At Hospitals, medical centres and polyclinic | Transforming Patient Care through Strategic Clinical Leadership | Quality & Patient Safety Expert The Era of CardiovascularKidneyMetabolic (CKM) Medicine Has Arrived Published online on 9 June 2026, the new AHA/ACC/ADA/ASN CKM Syndrome Guideline is the first comprehensive multisociety guideline to address obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease as one interconnected disease continuum

Its a big reason why she also emphasizes staying active while on a GLP-1, especially fitting in at least 30 minutes of strength training two to three times per weekfor stronger muscles and insulin sensitivity